Experimental group:Chinese medicine
Sponsors
First Affiliated Hospital, Guangzhou University of Chinese Medicine, Yueyang Hospital of integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Beijing Anding Hospital, Capital Medical University, Guangdong Provincial Hospital of Chinese Medicine
Conditions
AdenomyosisGastroesophageal Reflux DiseasePremature ovarian insufficiency(POI)and cardiovascular diseaseStable Coronary Artery DiseaseType 2 Diabetesbipolar disorderinfertility
Early Phase 1
Therapy of replenishing yin and regulating yang for manic episode in bipolar disorder: a randomized controlled trial
Active, not recruitingITMCTR2100005109
Start: 2021-08-01Updated: 2023-02-20
Therapy of replenishing yin and regulating yang for manic episode in bipolar disorder: a randomized controlled trial
Active, not recruitingChiCTR2100049300
Start: 2021-08-01Updated: 2022-04-04
Risk factors for cardiovascular disease in patients with premature ovarian insufficiency: A prospective non-randomized controlled study.
RecruitingChiCTR2100050130
Start: 2020-06-01Updated: 2022-04-25
A Study on the Screening of Biomarkers of Kidney Yin Deficiency Syndrome Based on Lncrna Expression Spectrum
RecruitingChiCTR2100052522
Start: 2021-10-25Updated: 2022-10-17
Unknown Phase
Syndrome differentiation in the management of Chronic Stable Coronary Artery Disease (SCAD) to improve quality
RecruitingChiCTR-OOC-16010058
Start: 2016-12-01Updated: 2017-04-18
A Randomized, Parallel Controlled Trial for Gastroesophageal Reflux Disease with Chinese Medicine in Southern China
Active, not recruitingChiCTR1800016127
Start: 2018-06-01Updated: 2018-05-21
A multicenter clinical study for Xiaoke formula based on PTP1B inhibition in the treatment of refractory type 2 diabetes mellitus
Active, not recruitingITMCTR1900002706
Start: 2019-11-30Updated: 2023-02-20
A multicenter clinical study for Xiaoke formula based on PTP1B inhibition in the treatment of refractory type 2 diabetes mellitus
Active, not recruitingChiCTR1900026815
Start: 2019-11-30Updated: 2019-10-28
Study on the clinical effect evaluation of Chinese patent medicine combined regimen for adenomyosis
RecruitingITMCTR2000002910
Start: 2020-01-01Updated: 2023-02-20
Study on the clinical effect evaluation of Chinese patent medicine combined regimen for adenomyosis
RecruitingChiCTR2000029029
Start: 2020-01-01Updated: 2020-01-20